Bio-Path Holdings (BPTH) Misses Q1 EPS by 1c

Bio-Path Holdings (NASDAQ: BPTH) reported Q1 EPS of ($0.02), $0.01 worse than the analyst estimate of ($0.01).

For earnings history and earnings-related data on Bio-Path Holdings (BPTH) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Innovaro (INV) Misses Q2 EPS by 9c
• Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Tops Q2 EPS by 24c